press to zoom
1/1

IPHARMA is a contract research organization specialized in conducting clinical trials of investigational drugs in the Russian Federation and the EAEU.

 

IPHARMA is a member of ChemRar High-Tech Center group of companies and an accredited partner of Skolkovo Innovation Center.

 

Download our company presentation

EAEU.jpg
IPHARMA results 
IPHARMA  #1 CRO by the number of CTAs in 2020

150+

180+

100

16

820+

17500+

25+

50+

Drug products in clinical pipline

Protocols written

CTA approvals

Clinical trials on COVID-19

Clinical sites

Subjects enrolled

Audits passed 

Original medical devices registered

If you would like to report an adverse drug reaction, you can do this

by phone: +7 (495) 276-11-43

e-mail: sae@ipharma.ru

or by filling out the online form on the website.

IPHARMA is now collecting information on Normacor®.

Advantages of working with IPHARMA

1. Leading positions on the market of Russian innovative drugs according to ACTO analytical report for 2013 - 2020.

2. Opportunities for drug localization, investments, and market access.

3. Full cycle of drug development: formulation, batches, QC, preclinical, clinical.

4. Medical and PV expertise with access to top scientists and KOLs.

5. Quality management systems and experienced staff.

IPHARMA contacts

 

Skolkovo Innovation Center, 

Business center "Amalteya",

40, Bolshoy Boulevard, 2 floor, office 77

121205, Moscow, Russia


Tel.: +7 (495) 276-11-43 
Fax: +7 (495) 276-11-47


E-mail: info@ipharma.ru

Personal data processing and storage policy

Sk_new_logo_22.png